Oncozyme Pharma

Québec invests in public-private partnership for personalized cancer medicine

Wednesday, February 20, 2013

The Québec government has invested $10 million in the Personalized Medicine Partnership for Cancer (PMPC), a public-private partnership focused on establishing an integrated approach for the development and implementation of clinical biomarkers and other personalized healthcare solutions to improve the outcome and cost-efficiency of healthcare services provided to cancer patients.

[Read More]